Contact this trialFirst, we need to learn more about you.
Proteasome Inhibitor
Daratumumab Combination Therapy for Multiple Myeloma
Recruiting1 awardPhase 2
Basking Ridge, New Jersey
This trial is testing a new treatment combining four drugs to see if it is safe for patients with multiple myeloma. The drugs work together to attack cancer cells in different ways, making it harder for the cancer to survive. The introduction of new treatments has greatly improved survival outcomes.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service